• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Database Analysis on the Relationships Between Nonsteroidal Anti-inflammatory Drug Treatment Variables and Incidence of Acute Myocardial Infarction in Japanese Patients with Osteoarthritis and Chronic Low Back Pain.数据库分析日本骨关节炎和慢性下背痛患者中,非甾体抗炎药治疗变量与急性心肌梗死发生率之间的关系。
Adv Ther. 2021 Mar;38(3):1601-1613. doi: 10.1007/s12325-021-01629-6. Epub 2021 Feb 5.
2
A Retrospective Database Study of Gastrointestinal Events and Medical Costs Associated with Nonsteroidal Anti-Inflammatory Drugs in Japanese Patients of Working Age with Osteoarthritis and Chronic Low Back Pain.一项回顾性数据库研究:日本工作年龄的骨关节炎和慢性下腰痛患者使用非甾体抗炎药的胃肠道事件和医疗费用。
Pain Med. 2021 May 21;22(5):1029-1038. doi: 10.1093/pm/pnaa421.
3
Safety risk associated with use of nonsteroidal anti-inflammatory drugs in Japanese elderly compared with younger patients with osteoarthritis and/or chronic low back pain: A retrospective database study.与使用非甾体抗炎药相关的安全性风险在日本老年骨关节炎和/或慢性下背痛患者与年轻患者中的比较:一项回顾性数据库研究。
Pain Pract. 2022 Feb;22(2):200-209. doi: 10.1111/papr.13079. Epub 2021 Oct 4.
4
Burden of Renal Events Associated with Nonsteroidal Anti-inflammatory Drugs in Patients with Osteoarthritis and Chronic Low Back Pain: A Retrospective Database Study.骨关节炎和慢性下腰痛患者中与非甾体抗炎药相关的肾脏事件负担:一项回顾性数据库研究
Pain Ther. 2021 Jun;10(1):443-455. doi: 10.1007/s40122-020-00233-w. Epub 2021 Jan 13.
5
Risk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): a case-crossover study of Taiwan's National Health Insurance claims database and review of current evidence.使用口服和注射用非甾体抗炎药(NSAIDs)与新发急性心肌梗死住院风险相关:基于台湾全民健康保险理赔数据库的病例交叉研究和当前证据综述。
BMC Cardiovasc Disord. 2012 Feb 2;12:4. doi: 10.1186/1471-2261-12-4.
6
Patterns of Comorbidities and Prescribing and Dispensing of Non-steroidal Anti-inflammatory Drugs (NSAIDs) Among Patients with Osteoarthritis in the USA: Real-World Study.美国骨关节炎患者共病模式及非甾体抗炎药(NSAIDs)的处方与配药情况:真实世界研究。
Drugs Aging. 2024 Apr;41(4):357-366. doi: 10.1007/s40266-024-01108-x. Epub 2024 Mar 23.
7
Differences in cardiovascular safety with non-steroidal anti-inflammatory drug therapy-A nationwide study in patients with osteoarthritis.非甾体抗炎药治疗的心血管安全性差异 - 一项全国范围内的骨关节炎患者研究。
Basic Clin Pharmacol Toxicol. 2019 May;124(5):629-641. doi: 10.1111/bcpt.13182. Epub 2019 Jan 4.
8
Potential Channeling Bias in the Evaluation of Cardiovascular Risk: The Importance of Comparator Selection in Observational Research.评估心血管风险时的潜在渠道偏差:观察性研究中对照选择的重要性。
Pharmaceut Med. 2022 Aug;36(4):247-259. doi: 10.1007/s40290-022-00433-z. Epub 2022 Jul 4.
9
Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis.非选择性非甾体抗炎药与急性心肌梗死风险:一项荟萃分析
Arthritis Res Ther. 2006;8(5):R153. doi: 10.1186/ar2047.
10
[Risk of fatal/non-fatal events in patients with previous coronary heart disease/acute myocardial infarction and treatment with non-steroidal anti-inflammatory drugs].[既往有冠心病/急性心肌梗死且接受非甾体抗炎药治疗的患者发生致命/非致命事件的风险]
Semergen. 2018 Jul-Aug;44(5):355-363. doi: 10.1016/j.semerg.2017.07.004. Epub 2017 Sep 4.

引用本文的文献

1
Innovative Approaches for the Treatment of Spinal Disorders: A Comprehensive Review.脊柱疾病治疗的创新方法:全面综述
J Orthop Sports Med. 2025;7(1):144-161. doi: 10.26502/josm.511500190. Epub 2025 Mar 27.
2
Comparison of Efficacies of a Blonanserin Transdermal Patch and Blonanserin Oral Formulation for Psychiatric Symptoms in Patients With Schizophrenia Treated With Laxatives Using a Japanese Claims Database.使用日本索赔数据库比较布南色林透皮贴剂与布南色林口服制剂对使用泻药治疗的精神分裂症患者精神症状的疗效
Neuropsychopharmacol Rep. 2025 Mar;45(1):e70003. doi: 10.1002/npr2.70003.
3
Use of analgesics before and after total joint replacement in working-age Japanese patients with knee and hip osteoarthritis: A retrospective database study.日本工作年龄的膝和髋骨关节炎患者全关节置换术前和术后镇痛药的使用:一项回顾性数据库研究
Asia Pac J Sports Med Arthrosc Rehabil Technol. 2023 Nov 3;35:1-8. doi: 10.1016/j.asmart.2023.10.002. eCollection 2024 Jan.
4
Safety risk associated with use of nonsteroidal anti-inflammatory drugs in Japanese elderly compared with younger patients with osteoarthritis and/or chronic low back pain: A retrospective database study.与使用非甾体抗炎药相关的安全性风险在日本老年骨关节炎和/或慢性下背痛患者与年轻患者中的比较:一项回顾性数据库研究。
Pain Pract. 2022 Feb;22(2):200-209. doi: 10.1111/papr.13079. Epub 2021 Oct 4.
5
Myofascial Release for Chronic Low Back Pain: A Systematic Review and Meta-Analysis.肌筋膜松解术治疗慢性下腰痛:一项系统评价与荟萃分析。
Front Med (Lausanne). 2021 Jul 28;8:697986. doi: 10.3389/fmed.2021.697986. eCollection 2021.

本文引用的文献

1
Treatment and Healthcare Cost Among Patients with Hip or Knee Osteoarthritis: A Cross-sectional Study Using a Real-world Claims Database in Japan Between 2013 and 2019.2013 年至 2019 年日本真实世界理赔数据库中髋关节或膝关节骨关节炎患者的治疗和医疗保健费用:一项横断面研究。
Clin Drug Investig. 2020 Nov;40(11):1071-1084. doi: 10.1007/s40261-020-00968-6.
2
Increased risk of strokes in patients with chronic low back pain (CLBP): A nationwide population-based cohort study.慢性下背痛(CLBP)患者中风风险增加:一项全国基于人群的队列研究。
Clin Neurol Neurosurg. 2020 May;192:105725. doi: 10.1016/j.clineuro.2020.105725. Epub 2020 Feb 6.
3
Role of Nonsteroidal Antiinflammatory Drugs in the Association Between Osteoarthritis and Cardiovascular Diseases: A Longitudinal Study.非甾体抗炎药在骨关节炎与心血管疾病相关性中的作用:一项纵向研究。
Arthritis Rheumatol. 2019 Nov;71(11):1835-1843. doi: 10.1002/art.41027. Epub 2019 Sep 5.
4
Patterns of drug treatment in patients with osteoarthritis and chronic low back pain in Japan: a retrospective database study.日本骨关节炎和慢性下腰痛患者的药物治疗模式:一项回顾性数据库研究。
J Pain Res. 2019 May 21;12:1631-1648. doi: 10.2147/JPR.S203553. eCollection 2019.
5
Low Back Pain, a Comprehensive Review: Pathophysiology, Diagnosis, and Treatment.下背痛:全面综述——病理生理学、诊断与治疗。
Curr Pain Headache Rep. 2019 Mar 11;23(3):23. doi: 10.1007/s11916-019-0757-1.
6
The Global Burden of Musculoskeletal Pain-Where to From Here?全球肌肉骨骼疼痛负担——路在何方?
Am J Public Health. 2019 Jan;109(1):35-40. doi: 10.2105/AJPH.2018.304747. Epub 2018 Nov 29.
7
Reducing the global burden of musculoskeletal conditions.减轻全球肌肉骨骼疾病负担。
Bull World Health Organ. 2018 May 1;96(5):366-368. doi: 10.2471/BLT.17.204891. Epub 2018 Apr 12.
8
Prevalence of Chronic Nonspecific Low Back Pain and Its Associated Factors among Middle-Aged and Elderly People: An Analysis Based on Data from a Musculoskeletal Examination in Japan.日本中老年人慢性非特异性下腰痛的患病率及其相关因素:基于肌肉骨骼检查数据的分析
Asian Spine J. 2017 Dec;11(6):989-997. doi: 10.4184/asj.2017.11.6.989. Epub 2017 Dec 7.
9
Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data.非甾体抗炎药在实际应用中导致急性心肌梗死的风险:个体患者数据的贝叶斯荟萃分析
BMJ. 2017 May 9;357:j1909. doi: 10.1136/bmj.j1909.
10
Prevalence of frailty in Japan: A systematic review and meta-analysis.日本衰弱症的患病率:一项系统评价与荟萃分析。
J Epidemiol. 2017 Aug;27(8):347-353. doi: 10.1016/j.je.2016.09.008. Epub 2016 Nov 15.

数据库分析日本骨关节炎和慢性下背痛患者中,非甾体抗炎药治疗变量与急性心肌梗死发生率之间的关系。

Database Analysis on the Relationships Between Nonsteroidal Anti-inflammatory Drug Treatment Variables and Incidence of Acute Myocardial Infarction in Japanese Patients with Osteoarthritis and Chronic Low Back Pain.

机构信息

Department of Public Health, Aichi Medical University School of Medicine, Aichi, Japan.

Pfizer Japan Inc., Tokyo, Japan.

出版信息

Adv Ther. 2021 Mar;38(3):1601-1613. doi: 10.1007/s12325-021-01629-6. Epub 2021 Feb 5.

DOI:10.1007/s12325-021-01629-6
PMID:33544304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7932944/
Abstract

INTRODUCTION

We aimed to analyze the relationships between nonsteroidal anti-inflammatory drug (NSAID) treatment variables and the incidence of acute myocardial infarction (AMI) in Japanese patients with osteoarthritis (OA) and chronic low back pain (CLBP) using the data from a large-scale, real-world database.

METHODS

We retrospectively analyzed anonymized claims data from the Japanese Medical Data Center of medical insurance beneficiaries who were prescribed NSAIDs for OA and/or CLBP from 2009 to 2018.

RESULTS

Of 180,371 patients, 89.3% received NSAIDs as first-line analgesics (oral, 90.3%; patch, 80.4%; other transdermal drugs, 24.0%). Incidence of AMI was 10.27 per 10,000 person-years (95% confidence interval 9.20-11.34) in the entire study population. There was a trend towards increased risk in patients using NSAIDs for more than 5 years (P = 0.0784) than in those using NSAIDs for less than 1 year. Risk of AMI significantly increased with age and comorbidities of diabetes and cardiovascular disease (CVD). The risk for AMI was similar for patients who consistently used NSAIDs compared to those using them intermittently and patients who used patch compared to oral NSAIDs. Elderly patients used NSAIDs more consistently and used NSAID patches more frequently.

CONCLUSION

In Japanese patients with OA and CLBP, we saw a trend of increased risk for AMI in patients using NSAIDs for more than 5 years. Elderly patients had a higher prevalence of diabetes, hypertension, and other CVD which increased the risk of AMI. Although NSAID patches were preferred to oral NSAIDs in elderly patients, risk for AMI was similar between the two modalities. Therefore, we suggest using NSAIDs carefully, especially in elderly patients and those at risk of developing CVD.

摘要

简介

本研究旨在利用大型真实世界数据库中的数据,分析非甾体抗炎药(NSAID)治疗变量与日本骨关节炎(OA)和慢性下腰痛(CLBP)患者发生急性心肌梗死(AMI)的关系。

方法

我们回顾性分析了日本医疗保险受益人的匿名索赔数据,这些人在 2009 年至 2018 年间因 OA 和/或 CLBP 接受 NSAID 治疗。

结果

在 180371 名患者中,90.3%(口服 90.3%;贴剂 80.4%;其他透皮药物 24.0%)接受 NSAID 作为一线镇痛药。在整个研究人群中,AMI 的发生率为 10.27/10000 人年(95%置信区间 9.20-11.34)。与使用 NSAID 不到 1 年的患者相比,使用 NSAID 超过 5 年的患者发生 AMI 的风险呈上升趋势(P=0.0784)。年龄和糖尿病及心血管疾病(CVD)等合并症的存在与 AMI 风险增加相关。与间歇性使用 NSAID 的患者相比,持续使用 NSAID 的患者和使用 NSAID 贴剂的患者发生 AMI 的风险相似。老年患者更持续地使用 NSAID,并更频繁地使用 NSAID 贴剂。

结论

在日本 OA 和 CLBP 患者中,我们发现使用 NSAID 超过 5 年的患者 AMI 风险呈上升趋势。老年患者糖尿病、高血压和其他 CVD 的患病率较高,增加了 AMI 的风险。尽管老年患者更喜欢 NSAID 贴剂而非口服 NSAID,但两种方式的 AMI 风险相似。因此,我们建议谨慎使用 NSAID,特别是在老年患者和有发生 CVD 风险的患者中。